Elixinol CBD Congratulates New York Giant Leonard Marshall on NFL Hall of Fame Nomination
September 18, 2017 07:00 ET
|
Elixinol
DENVER, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Two-time Super Bowl Champion and All-Pro for the New York Giants Leonard Marshall has been nominated for the NFL Hall of Fame. Videos accompanying this...
Kalytera Receives IRB Approval for Proposed Phase 2 Study Evaluating CBD in the Prevention of Graft versus Host Disease
September 07, 2017 08:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO, Calif. and TEL AVIV, Israel, Sept. 07, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF), a clinical-stage pharmaceutical company developing...
Kalytera Reports Second Quarter 2017 Financial Results
August 31, 2017 08:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Aug. 31, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSXV:KALY) (OTCQB:KALTF), a clinical-stage pharmaceutical company developing cannabinoid...
AXIM Biotechnologies Reports Second Quarter 2017 Results
August 22, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Aug. 22, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced results for the quarter...
Earth Science Tech, Inc. Announces Partnership with Bionatus to Help Manufacture, Distribute, & Continue Further R&D on Cannabis (CBD) Products
August 22, 2017 08:25 ET
|
Earth Science Tech, Inc.
Hollywood, FL, Aug. 22, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid...
Kalytera Submits Phase 2 Study Protocol to IRBs for Cannabidiol in the Prevention of Graft versus Host Disease
August 14, 2017 08:30 ET
|
Kalytera Therapeutics, Inc.
SAN FRANCISCO and TEL AVIV, Israel, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX-V:KALY) (OTCQB:KALTF), a clinical-stage pharmaceutical company developing cannabinoid...
Indoor Harvest Commences New Strategic Direction with Board Appointments
August 10, 2017 09:38 ET
|
Indoor Harvest Corp
Focus Shifts to Becoming State-of-the-Art Cannabis Producer and Technology ProviderFinalizing Plans for Facilities in Arizona and Colorado HOUSTON, Aug. 10, 2017 (GLOBE NEWSWIRE) -- Indoor Harvest...
Earth Science Tech, Inc. Signs Contract with Absolu to Advance Phase-2 Rollout on MSN-2 Medical Device
August 03, 2017 08:35 ET
|
Earth Science Tech, Inc.
Hollywood, FL, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of hemp cannabinoid,...
AXIM Biotech Enters Clinical Study Agreement with University of British Columbia to Begin Clinical Trial On CBD Chewing Gum For Treatment of Drug-Related Psychosis
August 02, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Aug. 02, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has entered into a...
Earth Science Tech Inc. Signs Contract with CDBQ to Advance Phase-2 Rollout on it’s CBD Patents
August 01, 2017 08:25 ET
|
Earth Science Tech, Inc.
Hollywood, FL, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotechnology company that operates in the fields of hemp...